Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy 0.5 mg is the second step on the licensed titration schedule, and UK private prices for this dose typically sit within the broader market range of roughly £149–£375 per month depending on provider and dose, as widely reported following Novo Nordisk's pricing decisions. Because semaglutide is a prescription-only medicine, every legitimate supply must come via a clinical assessment by a registered prescriber — the full picture of how Wegovy works in the UK is worth reading before comparing costs. What you pay for at 0.5 mg is not just the pen: it is the clinical oversight that makes using it safely possible.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 0.5 mg weekly dose of semaglutide is not where the clinical story begins or ends. Under the licensed titration pathway, treatment starts at 0.25 mg for the first four weeks to let the body adjust, then moves to 0.5 mg, a step confirmed in the SmPC and reflected in NICE's technology appraisal TA875 for semaglutide (Wegovy). The appraisal's recommendation is grounded in the STEP 1 trial, which followed participants at the 2.4 mg maintenance dose, not at 0.5 mg: the roughly 15% average body-weight reduction seen over 68 weeks in that trial was achieved at full maintenance, published in the New England Journal of Medicine.
That context matters when you're looking at the Wegovy 0.5 price, which reflects a step in a longer journey, not a standalone treatment. The right question isn't just how much does 0.5 mg cost this month, it's what the full pathway costs, and whether the service around it is safe enough to get you there.
Curious about how much weight people actually lose on Wegovy? The answer depends heavily on reaching and sustaining the maintenance dose with proper clinical support.
A quoted price for a single 0.5 mg pen or one month's supply rarely tells the complete story. Across the UK private market, some providers charge separately for the initial consultation, the prescription itself, follow-up reviews before each dose change, and delivery. Add those together and a headline price that looked reasonable at first glance becomes considerably higher.
There's also the question of what happens at the 1 mg step and beyond. The cost of 1 mg Wegovy tends to be higher than 0.5 mg, and prices typically climb with each escalation. If a service prices the early doses attractively but charges heavily for the review that authorises moving up, you can find yourself stuck or paying more than you'd budgeted.
A more honest comparison is the total cost of reaching and staying at the dose that delivers results, with clinical oversight built in throughout. For a broader look at what providers charge across the full schedule, our Wegovy pricing overview sets out the market context clearly.
At nume, one price covers the consultation, the prescription, the medicine, and free tracked next-working-day delivery. No separate prescription fee. No charge for aftercare questions. No bill arrives when you need your dose reviewed before moving to the next pen. That is the full cost.
We are not the cheapest option on the market, and that's a deliberate position. Keeping clinical review rigorous (identity verified by photo ID, weight confirmed on video, your GP notified, every repeat checked by a GPhC-registered prescriber before dispatch) means the service costs what it costs. Our pharmacy holds GPhC premises registration 9012878, verifiable directly on the GPhC register.
If you order before 12pm on a weekday, your pen leaves our pharmacy the same day once the prescriber approves it. DPD delivers it the next working day. It's the kind of reliability that matters when you're trying to keep a weekly injection schedule, not least because missing a dose during titration is something to discuss with your prescriber rather than improvise around. The current price for each treatment is shown on our treatment page, we never print per-pen prices in editorial copy.
Semaglutide is a prescription-only medicine. The MHRA has documented large seizures of counterfeit weight-loss pens sold online, fake pens that have contained insulin rather than semaglutide, with serious consequences for some buyers. The MHRA's Yellow Card scheme allows anyone to report a suspect seller, and the regulator's guidance is clear: sellers offering these medicines without a prescription, via social media, or at prices far below the typical market range are red flags, not bargains.
If you want to understand what 0.5 mg Wegovy genuinely costs from a legitimate UK provider, the GPhC register lets you check any online pharmacy in seconds. If a provider isn't listed, walk away.
For anyone weighing up whether private treatment is right for them right now, our overview of weight-loss treatment options covers the full landscape, including how NHS access works and where private routes fit. The starting point at nume is always a free consultation, check your eligibility and start that conversation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.